Skip to Main Content

Paper Details

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials.
Clinical Infectious Diseases
370
2020
CD4, HIV, HIV disease, HIV type 1 RNA, Integrase, abacavir, bictegravir, cobicistat, dolutegravir, efavirenz, elvitegravir, human immunodeficiency virus, nucleoside, nucleoside/nucleotide reverse transcriptase, nucleotide, obesity, participants, people, person, rilpivirine, tenofovir alafenamide, tenofovir disoproxil fumarate, zidovudine
Author NameAffiliation
Paul E SaxBrigham and Women's Hospital, Harvard Medical School
Hans-Jürgen StellbrinkInfectious Disease Medical Center
  • 1 - 2

Datasets

Release 1.2